Recent breast cancer incidence trends according to hormone therapy use: The California Teachers Study cohort

Breast Cancer Research

Volumn 12, Issue 1, 2010, Pages

  Marshall, Sarah F ^a   Clarke, Christina A ^b,c   Deapen, Dennis ^d   Henderson, Katherine ^e   Largent, Joan ^a   Neuhausen, Susan L ^a   Reynolds, Peggy ^b   Ursin, Giske ^d,f   Horn Ross, Pamela L ^b   Stram, Daniel O ^d   Templeman, Claire ^d   Bernstein, Leslie ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHERN CALIFORNIA CANCER CENTER   (United States)

^c STANFORD CANCER INSTITUTE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER RECURRENCE; CANCER REGISTRY; GROUPS BY AGE; HUMAN; POPULATION RESEARCH; UNITED STATES; AGED; BREAST TUMOR; CHEMISTRY; COHORT ANALYSIS; ESTROGEN THERAPY; FEMALE; INCIDENCE; MIDDLE AGED;

ESTROGEN RECEPTOR;

AGED; BREAST NEOPLASMS; CALIFORNIA; COHORT STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RECEPTORS, ESTROGEN;

EID: 77956020980     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2467     Document Type: Article

References (25)

1. Robbins AS, Clarke CA. Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol 2007, 25:3437-3439. 10.1200/JCO.2007.11.4132, 17592152.
2. Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA. The decrease in breast cancer incidence in 2003 in the United States. N Engl J Med 2007, 356:1670-1674. 10.1056/NEJMsr070105, 17442911.
3. Glass AG, Lacey JV, Carreon JD, Hoover RN. Breast cancer incidence, 1986-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 2007, 99:1152-1161. 10.1093/jnci/djm059, 17652280.
4. Kerlikowske K, Miglioretti DL, Buist DSM, Walker R, Carney PA. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst 2007, 99:1335-1339. 10.1093/jnci/djm111, 17698950.
5. Li CI, Daling JR. Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995-2004. Cancer Epidemiol Biomarkers Prev 2007, 16:2773-2780. 10.1158/1055-9965.EPI-07-0546, 18086787.
6. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 2006, 24:e49-e50. 10.1200/JCO.2006.08.6504, 17114650.
7. Jemal A, Ward E, Thun MJ. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 2007, 9:R28. 10.1186/bcr1672, 1929089, 17477859.
8. Canfell K, Banks E, Moa AM, Beral V. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia. Med J Australia 2008, 188:641-644.
9. Allemand H, Seradour B, Weill A, Ricordeau P. Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend. Bull Cancer 2008, 95:11-15.
10. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 2007, 107:427-430. 10.1007/s10549-007-9566-z, 17453336.
11. Kliewer EV, Demers AA, Nugent ZJ. A decline in breast-cancer incidence. N Engl J Med 2007, 357:509-510. 10.1056/NEJMc071391, 17674464.
12. Johnston M. Breast cancer drop linked to fall in use of HRT. New Zealand Herald 2006, http://www.nzherald.co.nz/section/story.cfm?c_id=204&objectid=10416198
13. Kumle M. Declining breast cancer incidence and decreased HRT use. Lancet 2008, 372:608-610. 10.1016/S0140-6736(08)61255-6, 18722851.
14. Krieger N, Lowy I, Aronowitz R, Bigby J, Dickersin K, Garner E, Gaudillière JP, Hinestrosa C, Hubbard R, Johnson PA, Missmer SA, Norsigian J, Pearson C, Rosenberg CE, Rosenberg L, Rosenkrantz BG, Seaman B, Sonnenschein C, Soto AM, Thornton J, Weisz G. Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives. J Epidemiol Community Health 2005, 59:740-748. 10.1136/jech.2005.033316, 1733142, 16100311.
15. Hersh AL, Stefanick ML, Stafford RS. National use of postmenopausal hormone therapy: Annual trends and response to recent evidence. JAMA 2004, 291:47-53. 10.1001/jama.291.1.47, 14709575.
16. Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397, Writing Group for the Women's Health Initiative Investigators.
17. Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross PL, Peel D, Pinder R, Reynolds P, Sullivan-Halley J, West D, Wright W, Ziogas A, Ross RK. High breast cancer incidence rates among California teachers: results from the California Teachers Study United States. Cancer Causes Control 2002, 13:625-635. 10.1023/A:1019552126105, 12296510.
18. Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK. Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 2005, 97:805-812.
19. Esteve J, Benhamou E, Raymond L. Statistical Methods in Cancer Research. Descriptive Epidemiology 1994, 4. Lyon: International Agency for Research on Cancer.
20. Miller RG. Simultaneous Statistical Inference 1981, New York: Springer-Verlag, 2.
21. Clarke CA, Glaser SL. Declines in breast cancer after the WHI: apparent impact of hormone therapy. Cancer Causes Control 2007, 18:847-852. 10.1007/s10552-007-9029-1, 17619153.
22. Tabár L, Duffy SW, Vitak B, Chen H, Prevost TC. The natural history of breast carcinoma. Cancer 1999, 86:449-462. 10.1002/(SICI)1097-0142(19990801)86:3<449::AID-CNCR13>3.0.CO;2-Q, 10430253.
23. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003, 362:419-427. 10.1016/S0140-6736(03)14596-5, 12927427.
24. Brewster DH, Sharpe KH, Clark DI, Collins J. Declining breast cancer incidence and decreased HRT use. Lancet 2009, 373:459-460. 10.1016/S0140-6736(09)60165-3, 19200912.
25. Verkooijen HM, Koot VCM, Fioretta G, Heiden M, Schipper ME, Rapiti E, Peeters PH, Peterse JL, Bouchardy C. Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations. Breast Cancer Res Treat 2008, 107:389-395. 10.1007/s10549-007-9554-3, 17431760.